Multiple myeloma (MM) involves a malignant proliferation of a single clone of plasma cells.
The malignant plasma cells produce monoclonal protein (Immunoglobulin—Ig) in the blood and ...
34% of patients are asymptomatic at the time of presentation.
Anemia (73%) is the most common presentation of MM
Hypercalcemia (28%): anorexia, abdominal pain, somnolence, polydipsia, p...
Treatment varies by risk, stage of MM, patient characteristics.
Key determinant factor in choosing chemotherapy regimen is to establish transplant candidacy; if the patient is an autologous s...
http://myeloma.org/Main.action
https://www.nccn.org/patients/guidelines/content/PDF/myeloma-patient.pdf
The 5-year survival rate is around 50%.
Median survival by R...
C90.0 Multiple myeloma
C90.00 Multiple myeloma not having achieved remission
C90.01 Multiple myeloma in remission
C90.02 Multiple myeloma in relapse
109989006 Multiple myeloma
94704006 Mul...
MM is a plasma cell malignancy that causes end-organ damage.
Look for presence of “CRAB.”
Suspect MM if high total protein-to-albumin ratio is present.
Avoid nephrotoxins (radiographic co...
Sign up for a 10-day FREE Trial now and receive full access to all content.